Αποτελέσματα Αναζήτησης
Bristol Myers Squibb's pipeline is focused on research in therapeutic areas where we believe we have the best opportunity to deliver transformational medicines to patients.
- Events and Presentations
The website may also contain certain non-GAAP financial...
- Medicines
We are a global biopharmaceutical company focused on helping...
- Our research in oncology
Our portfolio and pipeline for genitourinary cancers spans...
- Events and Presentations
Our portfolio and pipeline for genitourinary cancers spans multiple tumor types including bladder, kidney, as well as prostate*. We are exploring immunotherapies and targeted agents across multiple stages of cancer with the goal of helping address the unique needs of GU cancer patients.
Our vision is to discover, develop, and deliver transformational medicines. Explore our recruiting trials through our easy-to-use experience. Patients are waiting. Choose filters to find specific trials in the BMS pipeline. To search for clinical trials with other recruiting statuses, please visit bolderscience.com.
30 Μαΐ 2018 · Learn more about how BMS is partnering with leading organizations to advance a deliberately-built oncology pipeline. Collaboration is key to driving innovation in Immuno-Oncology research.
Listed below are our clinical studies and approved indications for our marketed products in the related therapeutic area as of February 2, 2023.
Listed in this section are our clinical studies and approved indications for our marketed products in the related therapeutic area as of February 4, 2022.
Note: Above pipeline excludes clinical collaborations.
